dermatology Archives - Page 4 of 8 -

Pfizer’s Xeljanz follow-up abrocitinib gathers momentum

https://pharmaphorum.com/news/pfizers-xeljanz-follow-up-abrocitinib-gathers-momentum/

3rd Annual Dermatology Drug Development Summit

https://pharmaphorum.com/events/3rd-annual-dermatology-drug-development-summit/

Sanofi ups revenues forecasts as eczema drug Dupixent surges

https://pharmaphorum.com/news/sanofi-ups-revenues-forecasts-as-eczema-drug-dupixent-surges/

https://pharmaphorum.com/events/your-ultimate-guide-to-the-skin-microbiome/

Almirall takes option on Dermira’s eczema drug lebrikizumab

https://pharmaphorum.com/news/almirall-takes-option-on-dermiras-eczema-drug-lebrikizumab/

AbbVie gets crucial US approval for psoriasis drug Skyrizi

https://pharmaphorum.com/news/abbvie-gets-crucial-us-approval-for-psoriasis-drug-skyrizi/

Almirall signs atopic dermatitis R&D deal with Hitgen

https://pharmaphorum.com/news/almirall-signs-atopic-dermatitis-rd-deal-with-hitgen/

Lilly scores with two Olumiant trials in atopic dermatitis

https://pharmaphorum.com/news/lilly-scores-with-two-olumiant-trials-in-atopic-dermatitis/

Biotech strategy and nanomedicine: the pharmaphorum podcast

https://pharmaphorum.com/r-d/biotech-strategy-and-nanomedicine/

Search